ask="2.39"
ask_size="100"
average_daily_volume="396360"
bid="2.32"
bid_size="4900"
book_value="4.01"
change="+0.04"
change_from_200_day_moving_average="-3.06"
change_from_50_day_moving_average="-0.61"
change_from_52_week_high="-7.04"
change_From_52_week_low="0.31"
change_in_percent="+1.76%"
close="2.31"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.96"
ebitda="-30.59M"
eps_estimate_current_year="-2.08"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.69"
ex_dividend_date="N/A"
float_shares="8428000"
high="2.35"
high_52_weeks="9.35"
last_trade_date="1/10/2017"
last_trade_price="2.31"
last_trade_size="200"
last_trade_time="3:59pm"
low="2.24"
low_52_weeks="2.00"
market_capitalization="35.90M"
moving_average_200_day="5.37"
moving_average_50_day="2.92"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="12.08"
open="2.24"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-57.02%"
percent_change_from_50_day_moving_average="-20.95%"
percent_change_from_52_week_high="-75.29%"
percent_change_from_52_week_low="+15.50%"
previous_close="2.27"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.57"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15543000"
short_ratio="0.40"
stock_exchange="NGM"
symbol="NVLS"
volume="200895"
weeks_range_52="2.00 - 9.35"
